News

Divis Laboratories announced that the 36th Annual General Meeting(AGM) of the company will be held on 10 August 2026.

Divis Laboratories announced that the Board of Directors of the Company at its meeting held on 23 May 2026, inter alia, have recommended the final dividend of Rs 30 per equity Share (i.e. 1500%) , subject to the approval of the shareholders.

Net profit of Divi`s Laboratories rose 13.44% to Rs 751.00 crore in the quarter ended March 2026 as against Rs 662.00 crore during the previous quarter ended March 2025. Sales rose 9.52% to Rs 2831.00 crore in the quarter ended March 2026 as against Rs 2585.00 crore during the previous quarter ended March 2025.For the full year,net profit rose 17.21% to Rs 2568.00 crore in the year ended March 2026 as against Rs 2191.00 crore during the previous year ended March 2025. Sales rose 12.82% to Rs 10560.00 crore in the year ended March 2026 as against Rs 9360.00 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales2831.002585.00 10 10560.009360.00 13 OPM %32.9934.27 -32.5931.71 - PBDT1083.00971.00 12 3925.003318.00 18 PBT963.00864.00 11 3462.002916.00 19 NP751.00662.00 13 2568.002191.00 17 Powered by Capital Market - Live News

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 23 May 2026.

Net profit of Divi`s Laboratories declined 1.02% to Rs 583.00 crore in the quarter ended December 2025 as against Rs 589.00 crore during the previous quarter ended December 2024. Sales rose 12.29% to Rs 2604.00 crore in the quarter ended December 2025 as against Rs 2319.00 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales2604.002319.00 12 OPM %34.1832.04 - PBDT972.00825.00 18 PBT854.00726.00 18 NP583.00589.00 -1 Powered by Capital Market - Live News